Catégories
-
Adhesives
5
Amines
94
Amino Acids
182
Analytical Reagents
682
Antibiotics
253
Bioactive Small Molecules
726
Aroma Chemicals
209
Biochemicals
1017
Boronic Acids
4
Buffers
98
Building Blocks
1796
Carbohydrates
176
Catalysts
100
Chiral Compounds
54
Detergents
59
Diagnostic Raw Materials
253
Flavours and Fragrance Materials
208
Fluorinated Products
43
Furans
5
Gases in Solution
50
Grignard Reagents
23
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
327
Ion-Pair Reagents
24
Ligands
80
Organics
1318
Oxazoles
3
Peptide Reagents
89
Phenols
45
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
756
Salts
286
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
294
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
238
Water Analysis
12
L-Tyrosine disodium salt hydrate
(26504155 | 69847-45-6)
| CAS: | 69847-45-6 |
|---|---|
| Formule moléculaire: | C9H9NNa2O3 xH2O |
| Masse moléculaire: | 225.15 (Anhy.) |
| Disponibilité: | En stock |
|---|---|
| Téléchargements: | | |
| 26504155-25g | 25g | £30.90 | |
| 26504155-100g | 100g | £73.20 | |
| Commande en vrac | |||
| 26504155-25g | 25g | €43.30 | |
| 26504155-100g | 100g | €102.50 | |
| Commande en vrac | |||
| 26504155-25g | 25g | $46.40 | |
| 26504155-100g | 100g | $109.80 | |
| Commande en vrac | |||
Fiche de données de sécurité
spécification
Détails du produit
| Product Code | 26504155 | ||||
| Product Name | L-Tyrosine disodium salt hydrate | ||||
| Categories | Amino Acids Biochemicals Chiral Compounds Diagnostic Raw Materials | ||||
| CAS | 69847-45-6 | ||||
| Molecular Formula | C9H9NNa2O3 xH2O | ||||
| Molecular Weight | 225.15 (Anhy.) | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 2922500090 |
Spécifications du produit
| Water | max 16% | ||||
| pH | 11.0 - 14.4 | ||||
| Assay | 99% min | ||||
| Appearance | White powder |
Informations sur la sécurité
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|